Activity OverviewRheum2Learn 2.0 is case-based, fundamental clinical rheumatology education for residents. Each interactive activity includes three patient cases that focus on the care and assessment of individuals with rheumatologic diseases.Learn about the diverse nature of scleroderma and how it can affect multiple organ systems. The cases in this activity discuss Raynaud’s phenomenon, cutaneous manifestations of systemic sclerosis, and scleroderma renal crisis (SRC).Rheum2Learn 2.0 SeriesThis activity is part of a series. See all activities in the series below.Rheum2Learn 2.0: Crystalline ArthritisRheum2Learn 2.0: Infectious ArthritisRheum2Learn 2.0: Inflammatory MyopathiesRheum2Learn 2.0: Musculoskeletal DisordersRheum2Learn 2.0: Musculoskeletal ExaminationRheum2Learn 2.0: OsteoarthritisRheum2Learn 2.0: OsteoporosisRheum2Learn 2.0: Pediatric RheumatologyRheum2Learn 2.0: Rheumatic Manifestations of Systemic DiseaseRheum2Learn 2.0: Rheumatoid ArthritisRheum2Learn 2.0: Sjögren’s DiseaseRheum2Learn 2.0: SpondyloarthritisRheum2Learn 2.0: Systemic Lupus ErythematosusRheum2Learn 2.0: Systemic SclerosisRheum2Learn 2.0: System VasculitisRegistration is complimentary.Target AudienceResidents in training who may provide care for patients with rheumatic diagnoses in primary care, inpatient, critical care, and other clinical contexts.The activity may also be of interest to medical students, fellows in training, advanced practice providers, practicing physicians, and other health care professionals who seek to strengthen their clinical knowledge of rheumatic diseases.Learning ObjectivesUpon completion of this activity, participants should be able to:Identify the differential diagnosis and appropriate workup for primary versus secondary Raynaud’s phenomenonInterpret the 2013 ACR/EULAR classification criteria for systemic sclerosis (SSc) and apply it to a patient caseDistinguish limited vs. diffuse systemic sclerosis based on the extent of skin involvementIdentify first line pharmacologic and non-pharmacologic treatments for Raynaud’s phenomenon and cutaneous manifestations of systemic sclerosisReview the differential diagnosis for shortness of breath in a patient with systemic sclerosisHighlight cardiopulmonary disease (interstitial lung disease and pulmonary arterial hypertension) as the major causes of mortality in systemic sclerosisDescribe risk factors associated with an increased risk for scleroderma renal crisis (SRC)Review the typical clinical presentation and laboratory findings of scleroderma renal crisis for diagnosis and prognosisOutline the approach to the treatment of scleroderma renal crisis emphasizing prompt need to control blood pressure with ACE inhibitor therapyUnderstand the implications of scleroderma renal crisis on prognosis in systemic sclerosisCE & MOC InformationThis activity is not eligible for CME/MOC.Acknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.